INVESTOR SINCE MARCH 2021
Employees: 11-50
Total raised: $12.32M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | 415 Capita... | 415capital... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.09.2018 | Seed | $9.7M | - |
| 24.10.2017 | Seed | $2.62M | - |
Mentions in press and media 9
| Date | Title | Description |
| 24.10.2019 | CorFlow receives the FDA Breakthrough Device Designation | |
| 07.06.2019 | CAScination wins the Swiss Medtech Award 2019 | |
| 09.05.2019 | CorFlow to start Clinical Trial with Inselspital | |
| 07.05.2019 | Erfahrene Leute für's Wachstum | |
| 30.11.2018 | CHF1.7 million grant for CorFlow | |
| 12.09.2018 | CorFlow Completes $9.7M Seed Funding | CorFlow Therapeutics AG, a Baar, Switzerland-based company developing proprietary technologies for diagnosis and treatment of microvascular obstructions (MVO), completed the 2nd close of its Seed+ financing round. To date, since foundation ... |
| 12.09.2018 | CorFlow Secures USD 9.7M in Seed Funding | |
| 24.10.2017 | CorFlow raises CHF 2.6M in seed+ financing round | |
| 24.10.2017 | CorFlow Completes CHF 2.6M First Close of Seed+ Financing Round | CorFlow Therapeutics AG, a Baar, Switzerland-based completed the CHF 2.6M first close of its seed+ financing round. The round was led by private medical device investors including Dr. Jean-Claude Laborde, who were joined by medical device e... |